Financials data is unavailable for this security.
View more
Year on year Zymeworks Inc 's revenues fell -81.57% from 412.48m to 76.01m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 124.34m to a loss of 118.67m.
| Gross margin | -- |
|---|---|
| Net profit margin | -182.75% |
| Operating margin | -222.37% |
| Return on assets | -21.79% |
|---|---|
| Return on equity | -28.73% |
| Return on investment | -25.64% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Zymeworks Inc fell by 243.36m. Cash Flow from Financing totalled 81.85m or 107.68% of revenues. In addition the company used 118.30m for operations while cash used for investing totalled 207.25m.
| Cash flow per share | -1.41 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 5.23 |
|---|---|
| Tangible book value per share | 4.97 |
More ▼
Balance sheet in USDView more
| Current ratio | 4.10 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00009 |
|---|---|
| Total debt/total capital | 0.00009 |
More ▼
